Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Sanofi tags newly OK'd MS drug Lemtrada at $158K, ready to tout head-to-head Rebif data
Sanofi tags newly OK'd MS drug Lemtrada at $158K, ready to tout head-to-head Rebif data
Sanofi tags newly OK'd MS drug Lemtrada at $158K, ready to tout head-to-head Rebif data
Submitted by
admin
on November 18, 2014 - 11:01am
Source:
Fierce Pharma Marketing
News Tags:
Sanofi
Lemtrada
MS
multiple sclerosis
Headline:
Sanofi tags newly OK'd MS drug Lemtrada at $158K, ready to tout head-to-head Rebif data
Do Not Allow Advertisers to Use My Personal information
